NXL
Nexalin Technology, Inc.
Price Chart
Latest Quote
$0.36
-0.01 (-3.20%)
Current Price
| Previous Close | $0.37 |
| Open | $0.36 |
| Day High | $0.38 |
| Day Low | $0.36 |
| Volume | 41,733 |
Stock Information
| Shares Outstanding | 21.54M |
| Cash Equivalents | $2.71M |
| Revenue | $276K |
| Net Income | $-8.33M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $7.76M |
| EPS (TTM) | $-0.46 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.95M |
| Sales | $276K |
| Income | $-8.33M |
| Book/sh | $0.14 |
| Cash/sh | $0.13 |
| Employees | 8 |
Financial Ratios
| Quick Ratio | 3.40 |
| Current Ratio | 4.07 |
Returns & Margins
| ROA | -161.11% |
| ROE | -319.69% |
| Gross Margin | 81.99% |
| Operating Margin | -14179.95% |
Ownership
| Insider Ownership | 11.23% |
| Institutional Ownership | 5.23% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.16 |
| P/S | 28.15 |
| P/B | 2.57 |
Analyst Data
| Recommendation | none |
| Target Price | $2.00 |
Technical Indicators
| SMA20 | $0.48 |
| SMA50 | $0.42 |
| SMA200 | $0.72 |
| RSI | 13.19 |
| ATR | 0.0493 |
| Shares Float | 17.86M |
| Short Float | 5.78% |
| Short Ratio | 0.97 |
| Volatility | 3.83 |
| Rel Volume | 0.09 |
Performance History
| Week | -10.84% |
| Month | -9.72% |
| Quarter | -11.28% |
| 6 Months | -55.25% |
| YTD | -38.22% |
| Year | -65.37% |
| 3 Years | -60.85% |
| 10 Years | -83.99% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $0.36 | 41,733 |
| 2026-06-22 | $0.37 | 111,400 |
| 2026-06-18 | $0.37 | 212,700 |
| 2026-06-17 | $0.39 | 166,600 |
| 2026-06-16 | $0.39 | 199,200 |
| 2026-06-15 | $0.40 | 134,300 |
| 2026-06-12 | $0.43 | 89,700 |
| 2026-06-11 | $0.47 | 136,900 |
| 2026-06-10 | $0.46 | 548,200 |
| 2026-06-09 | $0.45 | 191,000 |
| 2026-06-08 | $0.50 | 126,200 |
| 2026-06-05 | $0.52 | 504,500 |
| 2026-06-04 | $0.54 | 824,900 |
| 2026-06-03 | $0.53 | 158,200 |
| 2026-06-02 | $0.55 | 363,200 |
| 2026-06-01 | $0.58 | 348,600 |
| 2026-05-29 | $0.61 | 290,600 |
| 2026-05-28 | $0.58 | 563,600 |
| 2026-05-27 | $0.56 | 1,188,500 |
| 2026-05-26 | $0.48 | 2,991,000 |
About Nexalin Technology, Inc.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
đ° Latest News
EXCLUSIVE: Nexalin Brazil Trial Shows Benefits Across Anxiety, Sleep And Quality Of Life
Benzinga âĸ 2026-06-10T13:01:09Z
April 2026 Global's Top Undervalued Small Caps With Insider Action
Simply Wall St. âĸ 2026-04-17T09:39:38Z
ASX Stocks That May Be Trading Below Their Estimated Value
Simply Wall St. âĸ 2026-04-16T19:34:53Z
Three High Growth Tech Stocks in Australia
Simply Wall St. âĸ 2026-03-29T19:36:05Z
Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Deliver On Growth Plans?
Simply Wall St. âĸ 2025-10-10T10:36:45Z
Top Midday Gainers
MT Newswires âĸ 2025-10-08T18:09:33Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $61,373 | $36,593 | $25,688 | $363,212 |
| Cost Of Revenue | $61,373 | $36,593 | $25,688 | $363,212 |
| Total Revenue | $301,647 | $168,721 | $110,748 | $1,321,357 |
| Operating Revenue | $274,156 | $162,827 | $109,379 | $1,294,945 |
| Expenses | ||||
| Total Expenses | $8,692,528 | $7,923,367 | $5,807,044 | $3,154,388 |
| Other Income Expense | $161,508 | $139,420 | $1,086,422 | $194,597 |
| Other Non Operating Income Expenses | $34,568 | $9,310 | $239,542 | $171,681 |
| Net Non Operating Interest Income Expense | $8,240 | $3,193 | $-38,835 | $-59,382 |
| Operating Expense | $8,631,155 | $7,886,774 | $5,781,356 | $2,791,176 |
| General And Administrative Expense | $7,547,633 | $6,695,890 | $3,859,545 | $2,791,176 |
| Total Other Finance Cost | - | $-3,193 | $38,835 | $59,382 |
| Interest Expense | - | - | - | $59,382 |
| Interest Expense Non Operating | - | - | - | $59,382 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-8,222,181 | $-7,607,182 | $-4,648,709 | $-1,697,816 |
| Net Interest Income | $8,240 | $3,193 | $-38,835 | $-59,382 |
| Interest Income | $8,240 | - | - | - |
| Normalized Income | $-8,349,121 | $-7,737,292 | $-5,495,589 | $-1,720,732 |
| Net Income From Continuing And Discontinued Operation | $-8,222,181 | $-7,607,182 | $-4,648,709 | $-1,697,816 |
| Total Operating Income As Reported | $-8,390,881 | $-7,754,646 | $-5,696,296 | $-1,833,031 |
| Net Income Common Stockholders | $-8,222,181 | $-7,607,182 | $-4,648,709 | $-1,697,816 |
| Net Income | $-8,222,181 | $-7,607,182 | $-4,648,709 | $-1,697,816 |
| Net Income Including Noncontrolling Interests | $-8,222,181 | $-7,607,182 | $-4,648,709 | $-1,697,816 |
| Net Income Continuous Operations | $-8,222,181 | $-7,607,182 | $-4,648,709 | $-1,697,816 |
| Earnings From Equity Interest Net Of Tax | $-1,048 | $4,851 | $0 | - |
| Pretax Income | $-8,221,133 | $-7,612,033 | $-4,648,709 | $-1,697,816 |
| Interest Income Non Operating | $8,240 | - | - | - |
| Operating Income | $-8,390,881 | $-7,754,646 | $-5,696,296 | $-1,833,031 |
| Gross Profit | $240,274 | $132,128 | $85,060 | $958,145 |
| Special Income Charges | - | $0 | $615,000 | $22,916 |
| Per Share | ||||
| Diluted EPS | $-0.50 | $-0.83 | $-0.63 | $-0.30 |
| Basic EPS | $-0.50 | $-0.83 | $-0.63 | $-0.30 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-8,496,284 | $-7,869,649 | $-6,538,922 | $-1,855,412 |
| Total Unusual Items | $126,940 | $130,110 | $846,880 | $22,916 |
| Total Unusual Items Excluding Goodwill | $126,940 | $130,110 | $846,880 | $22,916 |
| Reconciled Depreciation | $21,537 | $15,107 | $4,254 | $535 |
| EBITDA (Bullshit earnings) | $-8,369,344 | $-7,739,539 | $-5,692,042 | $-1,832,496 |
| EBIT | $-8,390,881 | $-7,754,646 | $-5,696,296 | $-1,833,031 |
| Diluted Average Shares | $16,392,465 | $9,215,772 | $7,357,029 | $5,572,402 |
| Basic Average Shares | $16,392,465 | $9,215,772 | $7,357,029 | $5,572,402 |
| Diluted NI Availto Com Stockholders | $-8,222,181 | $-7,607,182 | $-4,648,709 | $-1,697,816 |
| Tax Provision | $0 | $0 | $0 | - |
| Gain On Sale Of Security | $126,940 | $130,110 | $231,880 | - |
| Research And Development | $1,083,522 | $1,190,884 | $1,921,811 | - |
| Selling General And Administration | $7,547,633 | $6,695,890 | $3,859,545 | $2,791,176 |
| Other Gand A | $5,668,350 | $5,195,801 | $2,471,629 | $2,097,068 |
| Salaries And Wages | $1,879,283 | $1,500,089 | $1,387,916 | $694,108 |
| Other Special Charges | - | - | $-615,000 | $-22,916 |
| Impairment Of Capital Assets | - | - | - | - |
Fetched: 2026-06-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,411,937 | $3,415,311 | $3,101,107 | $5,478,687 |
| Total Assets | $4,635,319 | $4,222,732 | $3,631,916 | $7,432,136 |
| Total Non Current Assets | $336,049 | $261,591 | $202,024 | $6,674 |
| Goodwill And Other Intangible Assets | $336,049 | $260,727 | $105,528 | $0 |
| Other Intangible Assets | $336,049 | $260,727 | $105,528 | - |
| Current Assets | $4,299,270 | $3,961,141 | $3,429,892 | $7,425,462 |
| Other Current Assets | $363,014 | $293,597 | $315,670 | $272,282 |
| Inventory | $131,473 | $174,578 | $156,420 | $154,370 |
| Receivables | $81,571 | $13,043 | $9,369 | $4,875 |
| Accounts Receivable | $81,571 | $13,043 | $9,369 | $4,875 |
| Cash Cash Equivalents And Short Term Investments | $3,723,212 | $3,479,923 | $2,948,433 | $6,993,935 |
| Cash And Cash Equivalents | $654,783 | $574,485 | $580,230 | $162,743 |
| Other Non Current Assets | - | $864 | - | - |
| Investmentin Financial Assets | - | - | $96,000 | $0 |
| Prepaid Assets | - | - | - | - |
| Cash Financial | - | - | - | - |
| Debt | ||||
| Total Debt | - | $0 | $4,463 | $755,260 |
| Long Term Debt And Capital Lease Obligation | - | - | $0 | $4,463 |
| Current Debt And Capital Lease Obligation | - | - | $4,463 | $750,797 |
| Net Debt | - | - | - | $537,257 |
| Current Debt | - | - | - | $700,000 |
| Other Current Borrowings | - | - | - | $200,000 |
| Long Term Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $887,333 | $546,694 | $425,281 | $1,953,449 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $4,463 |
| Current Liabilities | $887,333 | $546,694 | $425,281 | $1,948,986 |
| Payables And Accrued Expenses | $399,333 | $306,694 | $270,818 | $1,198,189 |
| Payables | $244,579 | $155,949 | $159,534 | $658,367 |
| Accounts Payable | $244,579 | $155,949 | $159,534 | $658,367 |
| Current Notes Payable | - | - | $0 | $500,000 |
| Interest Payable | - | - | $0 | $111,501 |
| Current Deferred Liabilities | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $3,747,986 | $3,676,038 | $3,206,635 | $5,478,687 |
| Total Equity Gross Minority Interest | $3,747,986 | $3,676,038 | $3,206,635 | $5,478,687 |
| Stockholders Equity | $3,747,986 | $3,676,038 | $3,206,635 | $5,478,687 |
| Gains Losses Not Affecting Retained Earnings | $406 | $-513 | $-405 | $36,313 |
| Other Equity Adjustments | $406 | $-513 | $-405 | $36,313 |
| Retained Earnings | $-92,867,412 | $-84,645,231 | $-77,038,049 | $-72,389,340 |
| Long Term Equity Investment | - | $864 | $96,000 | $0 |
| Other | ||||
| Ordinary Shares Number | $19,186,346 | $13,303,523 | $7,436,562 | $7,286,562 |
| Share Issued | $19,186,346 | $13,303,523 | $7,436,562 | $7,286,562 |
| Tangible Book Value | $3,411,937 | $3,415,311 | $3,101,107 | $5,478,687 |
| Invested Capital | $3,747,986 | $3,676,038 | $3,206,635 | $6,178,687 |
| Working Capital | $3,411,937 | $3,414,447 | $3,004,611 | $5,476,476 |
| Total Capitalization | $3,747,986 | $3,676,038 | $3,206,635 | $5,478,687 |
| Additional Paid In Capital | $96,595,806 | $88,308,478 | $80,237,652 | $77,824,427 |
| Capital Stock | $19,186 | $13,304 | $7,437 | $7,287 |
| Common Stock | $19,186 | $13,304 | $7,437 | $7,287 |
| Pensionand Other Post Retirement Benefit Plans Current | $488,000 | $240,000 | $150,000 | $0 |
| Current Accrued Expenses | $154,754 | $150,745 | $111,284 | $539,822 |
| Other Short Term Investments | $3,068,429 | $2,905,438 | $2,368,203 | $6,831,192 |
| Capital Lease Obligations | - | $0 | $4,463 | $55,260 |
| Current Capital Lease Obligation | - | $0 | $4,463 | $50,797 |
| Investments And Advances | - | $864 | $96,000 | $0 |
| Net PPE | - | $0 | $496 | $6,674 |
| Gross PPE | - | $0 | $496 | $8,855 |
| Long Term Capital Lease Obligation | - | - | $0 | $4,463 |
| Available For Sale Securities | - | - | $96,000 | - |
| Accumulated Depreciation | - | - | $-2,684 | $-2,181 |
| Other Properties | - | - | $496 | $8,855 |
| Current Deferred Revenue | - | - | - | $0 |
| Machinery Furniture Equipment | - | - | - | - |
Fetched: 2026-06-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-5,054,517 | $-4,114,696 | $-3,944,663 | $-2,215,699 |
| Operating Activities | ||||
| Operating Cash Flow | $-4,957,658 | $-3,944,390 | $-3,835,384 | $-2,215,699 |
| Cash Flow From Continuing Operating Activities | $-4,957,658 | $-3,944,390 | $-3,835,385 | $-2,215,699 |
| Operating Gains Losses | $-126,076 | $-34,974 | $-846,880 | $-22,916 |
| Investing Activities | ||||
| Capital Expenditure | $-96,859 | $-170,306 | $-109,279 | - |
| Investing Cash Flow | $-131,991 | $-577,539 | $4,452,872 | $-6,794,879 |
| Cash Flow From Continuing Investing Activities | $-131,991 | $-577,539 | $4,452,872 | $-6,794,879 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $4,646,397 | $4,516,184 | $0 | $8,545,270 |
| Financing Cash Flow | $5,169,947 | $4,516,184 | $-200,000 | $8,511,543 |
| Cash Flow From Continuing Financing Activities | $5,169,947 | $4,516,184 | $-200,000 | $8,511,543 |
| Net Common Stock Issuance | $4,646,397 | $4,516,184 | $0 | $8,545,270 |
| Common Stock Issuance | $4,646,397 | $4,516,184 | $0 | $8,545,270 |
| Other | ||||
| End Cash Position | $654,783 | $574,485 | $580,230 | $162,743 |
| Beginning Cash Position | $574,485 | $580,230 | $162,743 | $661,778 |
| Changes In Cash | $80,298 | $-5,745 | $417,487 | $-499,035 |
| Proceeds From Stock Option Exercised | $523,550 | $0 | $0 | $3,473 |
| Net Investment Purchase And Sale | $-35,132 | $-407,233 | $4,658,151 | $-6,794,879 |
| Sale Of Investment | $40,725,000 | $33,224,000 | $41,278,241 | $0 |
| Purchase Of Investment | $-40,760,132 | $-33,631,233 | $-36,620,090 | $-6,794,879 |
| Net Intangibles Purchase And Sale | $-96,859 | $-170,306 | $-109,279 | $0 |
| Purchase Of Intangibles | $-96,859 | $-170,306 | $-109,279 | $0 |
| Change In Working Capital | $229,419 | $121,654 | $-768,862 | $-634,066 |
| Change In Other Current Liabilities | $0 | $-4,463 | $-50,797 | $-46,033 |
| Change In Payables And Accrued Expense | $340,638 | $125,876 | $-662,371 | $-86,320 |
| Change In Accrued Expense | $252,009 | $129,461 | $-163,538 | $99,107 |
| Change In Payable | $88,629 | $-3,585 | $-498,833 | $-185,427 |
| Change In Account Payable | $88,629 | $-3,585 | $-498,833 | $-185,427 |
| Change In Prepaid Assets | $-69,417 | $22,073 | $-43,388 | $-229,114 |
| Change In Inventory | $26,725 | $-18,158 | $-7,812 | $-142,852 |
| Change In Receivables | $-68,527 | $-3,674 | $-4,494 | $253 |
| Changes In Account Receivables | $-68,527 | $-3,674 | $-4,494 | $253 |
| Stock Based Compensation | $3,123,263 | $3,560,509 | $2,413,375 | $270,670 |
| Asset Impairment Charge | $16,380 | $0 | $5,762 | $31,067 |
| Depreciation Amortization Depletion | $21,537 | $15,107 | $4,254 | $535 |
| Depreciation And Amortization | $21,537 | $15,107 | $4,254 | $535 |
| Amortization Cash Flow | $21,537 | $15,107 | $3,751 | $0 |
| Amortization Of Intangibles | $21,537 | $15,107 | $3,751 | $0 |
| Earnings Losses From Equity Investments | $864 | $95,136 | $0 | - |
| Gain Loss On Investment Securities | $-126,940 | $-130,110 | $-231,880 | - |
| Net Income From Continuing Operations | $-8,222,181 | $-7,607,182 | $-4,648,709 | $-1,697,816 |
| Repayment Of Debt | - | $0 | $-200,000 | $-37,200 |
| Net Issuance Payments Of Debt | - | $0 | $-200,000 | $-37,200 |
| Net Short Term Debt Issuance | - | $0 | $-200,000 | $-37,200 |
| Short Term Debt Payments | - | $0 | $-200,000 | $-37,200 |
| Net Business Purchase And Sale | - | $0 | $-96,000 | $0 |
| Purchase Of Business | - | $0 | $-96,000 | $0 |
| Other Non Cash Items | - | $496 | $5,676 | $-163,173 |
| Depreciation | - | $0 | $503 | $535 |
| Issuance Of Debt | - | - | - | $0 |
| Short Term Debt Issuance | - | - | - | $0 |
| Change In Other Working Capital | - | - | - | $-130,000 |
| Interest Paid Supplemental Data | - | - | - | - |
| Net Long Term Debt Issuance | - | - | - | - |
| Long Term Debt Payments | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
| Net PPE Purchase And Sale | - | - | - | - |
| Purchase Of PPE | - | - | - | - |
Fetched: 2026-06-21